: More effective treatment strategies are needed for the chronic skin ulcers. Recently, it has been reported that clinical application of stem cells improve wound healing.
We aimed to determine the dynamic time-course movement of epidermal stem cell markers especially p75 neurotrophin receptor (p75NTR) and Integrin beta-1 in wound healing process. Furthermore, we also investigated the presence of these markers in human.
Epidermal Integrin beta-1+ and p75NTR+ cells were counted in wound healing process in mice. Both cells were also counted in human skin specimen obtained from chronic skin ulcers and healthy controls. Growth factor gene expression levels by purified mouse epidermal p75NTR+ cells were also analyzed using real-time RT-PCR.
Integrin beta-1+ and p75NTR+ cells were proliferated from 3 days after wounding. Reepithelization was completed 7 days after wounding, and the numbers of cells were returned to the baseline levels by 14 days after wounding. Integrin beta-1+ cells were proliferated in the basal layer, and p75NTR+ cells were proliferated in the upper layer of epidermis. In human skin, Integrin beta-1+ and p75NTR+ cells were 81% ± 12% and 36% ± 15% of the basal cells, respectively. In patients with chronic skin ulcers, the percentage of Integrin beta-1+ cells in the epidermis was identical to healthy controls. Surprisingly, p75NTR+ cells were significantly decreased in chronic skin ulcer patients (1.2% ± 2.6%; p < 0.0005) compared to healthy controls. Purified mouse epidermal p75NTR+ cells expressed higher transforming growth factor-beta2 and vascular endothelial growth factor-alpha transcripts and lower epidermal growth factor transcripts than p75NTR− cells.
These results suggest that Integrin beta-1+ and p75NTR+ cells play an important role in wound healing process, and that p75NTR may be a key molecule and a candidate for new therapeutic target besides preexisting molecules for chronic skin ulcer patients.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Dermatological Science
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor.J Korean Med Sci. 2011; 26: 726-733
- Effects of human adipose-derived stem cells on cutaneous wound healing in nude mice.Ann Dermatol. 2011; 23: 150-155
- Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors.J Cell Physiol. 2007; 212: 702-709
- Identification of white adipocyte progenitor cells in vivo.Cell. 2008; 135: 240-249
- Age-related changes of p75 neurotrophin receptor-positive adipose-derived stem cells.J Dermatol Sci. 2010; 58: 36-42
- Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling.Stem Cells. 2007; 25: 628-638
- Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro.Oncogene. 2003; 22: 4017-4026
- Role of endothelial selectins in wound repair.Am J Pathol. 1997; 150: 1701-1709
- A cell-biological model of p75NTR signaling.J Neurochem. 2007; 102: 289-305
- Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Proc Natl Acad Sci USA. 1986; 83: 4167-4171
- Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats.Arch Otolaryngol Head Neck Surg. 1996; 122: 171-177
- The role of the TGF-beta family in wound healing, burns and scarring: a review.Int J Burns Trauma. 2012; 2: 18-28
- Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.Am J Pathol. 2004; 164: 1935-1947
- Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing.Mol Ther J Am Soc Gene Ther. 2013; 21: 445-455
- A global transcriptome analysis reveals molecular hallmarks of neural stem cell death, survival, and differentiation in response to partial fgf-2 and EGF deprivation.PLoS ONE. 2013; 8: e53594
- The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.Cell. 1994; 76: 959-962
- Signalling through the neurotrophin receptor p75NTR.Curr Opin Neurobiol. 1997; 7: 413-418
- Tumor necrosis factor p55 and p75 receptors are involved in chemical-induced apoptosis of dentate granule neurons.J Neurochem. 2008; 106: 281-298
- Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles.Circ Res. 2008; 103: e15-e26
- Expression pattern of p75 neurotrophin receptor protein in human scalp skin and hair follicles: hair cycle-dependent expression.J Am Acad Dermatol. 2009; 60: 99-109
- Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor.EMBO J. 1992; 11: 917-922
- Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin – an exploration of the cause of neurohyperplasia.Arch Dermatol Res. 2002; 293: 614-619
- Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.Arch Dermatol Res. 2006; 298: 31-37
- The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study.Arch Dermatol Res. 1996; 288: 670-675
- A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression.FASEB J. 2000; 14: 1931-1942
Published online: May 03, 2013
Accepted: April 11, 2013
Received in revised form: April 8, 2013
Received: October 22, 2012
© 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Inc. All rights reserved.